These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 1572039

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V, Bachmann F, Hauert J, Christe MA, Kruithof EK.
    Thromb Haemost; 1992 Apr 02; 67(4):397-401. PubMed ID: 1631786
    [Abstract] [Full Text] [Related]

  • 3. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G, Horellou MH, Kruithof EK, Conard J, Samama MM.
    Blood; 1988 Aug 02; 72(2):601-5. PubMed ID: 3135860
    [Abstract] [Full Text] [Related]

  • 4. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.
    Falkon L, Garí M, Borrell M, Fontcuberta J.
    Blood Coagul Fibrinolysis; 1992 Feb 02; 3(1):33-8. PubMed ID: 1623118
    [Abstract] [Full Text] [Related]

  • 5. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish LK, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan NP, Kozol RA.
    J Surg Res; 1998 Jan 02; 74(1):96-101. PubMed ID: 9536981
    [Abstract] [Full Text] [Related]

  • 6. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 7. [Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
    Jokaji H, Asakura H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T.
    Nihon Ronen Igakkai Zasshi; 1990 Nov 22; 27(6):699-705. PubMed ID: 2127812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
    Pedersen OD, Gram J, Bagger H, Keller N, Jespersen J.
    Coron Artery Dis; 1994 Jul 22; 5(7):617-23. PubMed ID: 7952424
    [Abstract] [Full Text] [Related]

  • 13. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
    Eriksson BI, Eriksson E, Gyzander E, Teger-Nilsson AC, Risberg B.
    Acta Orthop Scand; 1989 Apr 22; 60(2):159-63. PubMed ID: 2471386
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis.
    Meissner MH, Zierler BK, Bergelin RO, Chandler WL, Strandness DE.
    J Vasc Surg; 2002 Feb 22; 35(2):278-85. PubMed ID: 11854725
    [Abstract] [Full Text] [Related]

  • 18. Fibrinolytic response to venous occlusion for 10 and 20 minutes in healthy subjects and in patients with deep vein thrombosis.
    Petäjä J.
    Thromb Res; 1989 Oct 15; 56(2):251-63. PubMed ID: 2515609
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.